Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK2 |
Variant | Q34Vfs*42 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CHEK2 Q34Vfs*42 indicates a shift in the reading frame starting at amino acid 34 and terminating 42 residues downstream causing a premature truncation of the 543 amino acid Chek2 protein (UniProt.org). Q34Vfs*42 has not been characterized, however, due to the effects of other truncation mutations downstream of Q34 resulting in disruption of the protein kinase domain (PMID: 11053450, PMID: 16982735, PMID: 31050813), is predicted to lead to a loss of Chek2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 Q34Vfs*42 |
Transcript | NM_007194.4 |
gDNA | chr22:g.28734623_28734624delTG |
cDNA | c.100_101delCA |
Protein | p.Q34Vfs*42 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011529843 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
XM_011529841.1 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_007194.4 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_001005735 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_001349956.2 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_007194.3 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
XM_011529841 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_001005735.2 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
XM_047441105.1 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_145862 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_001349956.1 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_007194 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
XM_047441106.1 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
XM_047441104.1 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
NM_001005735.1 | chr22:g.28734623_28734624delTG | c.100_101delCA | p.Q34Vfs*42 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|